FACELIFT.STUDIO

Dexmedetomidine: a new alpha-agonist anesthetic agent for facial rejuvenation surgery

In 50 facelift patients sedated without a breathing tube, dexmedetomidine kept systolic blood pressure at 120 mm Hg or less in all but 8, with normal breathing throughout and no need for anti-nausea drugs.

2006
Aesthet Surg J
7
Citations, NIH iCite
2
Authors
3
Topics

Overview

The ideal added anesthetic drug sedates, relieves pain and anxiety, and keeps blood pressure predictable without slowing breathing. The authors asked whether dexmedetomidine meets these goals in facial surgery. They reviewed 50 randomly selected patients who had extended SMAS facelifts by one surgeon without a breathing tube, all with dexmedetomidine as the main sedative.

Findings

  • 50 patients; 47 women; mean age 56.1 years; extended SMAS facelift by one surgeon; 73 added procedures.
  • Continuous infusion of dexmedetomidine at 0.2 to 0.7 mcg/kg/h.
  • Systolic blood pressure stayed at 120 mm Hg or less over the 3 to 6.7 hour procedure in all but 8 patients, who needed a blood pressure drug during surgery.
  • Mean (SD) midazolam dose: 4.4 (1.3) mg; mean (SD) fentanyl dose: 201 (64) mcg; propofol drip added for more sedation.
  • All patients kept a normal breathing rate, without airway obstruction or low oxygen.
  • All went from the operating room directly to a stage 2 recovery area.
  • No patient needed anti-nausea medication after surgery.
  • 1 complication: a hematoma 72 hours after surgery.

What it means for a patient

  • A facelift can be done under sedation without a breathing tube.
  • In this group, dexmedetomidine helped keep blood pressure controlled during surgery, and no patient needed treatment for nausea.
  • 8 of 50 patients still needed another drug to lower blood pressure during surgery.
  • This is a small retrospective series from one surgeon, with no comparison group.

Why this paper matters

It is an early report of dexmedetomidine sedation in facelift surgery, with blood pressure, breathing and nausea results in 50 patients. The authors conclude it fulfilled the properties they sought in a sedative.

Terms

  • Dexmedetomidine: an alpha-agonist sedative that calms and eases pain with little effect on breathing.
  • Alpha-agonist: a drug that acts on alpha receptors, which can lower blood pressure and cause sedation.
  • Nonintubated: without a breathing tube in the windpipe.
  • Extended SMAS facelift: a facelift that lifts the deeper SMAS layer further toward the center of the face.
  • Systolic blood pressure: the top number in a blood pressure reading.
  • Hemodynamic stability: steady blood pressure and heart rate.
  • Hematoma: a collection of blood under the skin.

Newest papers on smas techniques

From the PubMed facelift record, newest first.

2026
Use of Ultrasound in Face and Neck Rejuvenation
Liao D, Prasad A, Bloom JD · Facial Plast Surg · PMID 41985490
2026
Effect of Age on Complications in Facelift Surgery
Vishwanath N, Mandelbaum M, Williams-Medina E, Darras O, Fraiman E, Patel V, et al. · Aesthet Surg J · PMID 42045665
2026
The Phylogeny and Ontogeny of Facial Superficial Musculoaponeurotic System
Ullas G, Garg S, Raghavan U · Facial Plast Surg · PMID 41061757
2026
Surgical Correction of the Nasolabial Fold: A Critical Review of Rhytidectomy Techniques
Atiyeh B, Baajour J, Chrabieh E, El Moughrabi C, Zeineddine J, Makkawi K, et al. · Plast Reconstr Surg Glob Open · PMID 42488922